Premium Oncology Biosimilar Solutions for Worldwide Healthcare Markets
Rituximab Biosimilar 100mg/500mg Injection is a clinically established anti-CD20 monoclonal antibody therapy widely used in modern oncology and immunology treatment protocols. With the increasing global shift toward affordable biologics and biosimilar cancer therapies, Rituximab has become one of the most in-demand injectable molecules in international pharmaceutical trade.
Cordium Pharmaceuticals Pvt Ltd is a rapidly growing India-based pharmaceutical exporter specializing in high-quality oncology biosimilars supplied to hospitals, specialty clinics, pharmacies, distributors, and personal import patients across regulated global markets.
🌐 Worldwide Export Destinations
Cordium Pharmaceuticals Pvt Ltd supplies Rituximab Biosimilar 100mg and 500mg Injection to key international healthcare markets, including:
- United States (USA) 🇺🇸
- Germany 🇩🇪
- United Kingdom (UK) 🇬🇧
- Netherlands 🇳🇱
- South Africa 🇿🇦
- United Arab Emirates (UAE) 🇦🇪
- Brazil 🇧🇷
These regions represent strong demand for biologic oncology drugs, hospital injectable imports, and immunotherapy biosimilars.
💊 Product Highlights – Rituximab Biosimilar Injection
Rituximab Biosimilar is engineered to selectively target the CD20 antigen present on B-cells, making it highly effective in controlling abnormal immune responses and malignant cell growth.
Available Strengths:
- Rituximab Biosimilar Injection 100mg
- Rituximab Biosimilar Injection 500mg
Therapeutic Applications:
- Non-Hodgkin’s Lymphoma (NHL) treatment support
- Chronic Lymphocytic Leukemia (CLL) management
- Autoimmune disease therapy (Rheumatoid Arthritis)
- Vasculitis-related conditions
- Other B-cell mediated disorders
🏥 Global Supply for Healthcare Institutions
Cordium Pharmaceuticals Pvt Ltd provides reliable export supply solutions for:
- Multispecialty & oncology hospitals
- Infusion therapy centers
- Government & private healthcare procurement agencies
- Wholesale pharmaceutical distributors
- Licensed pharmacies
- International personal import patients (prescription-based)
🚢 International Pharmaceutical Export Capabilities
As a trusted oncology biosimilar exporter from India, Cordium Pharmaceuticals ensures:
- GMP-aligned manufacturing sourcing
- Temperature-controlled biologics logistics (cold-chain shipping)
- Regulatory documentation support for exports
- Bulk supply and institutional contracts
- Safe packaging for international transit
- Efficient global distribution network
🌍 Why Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals is committed to delivering quality-driven pharmaceutical export solutions with a strong focus on oncology, biosimilars, and critical care injectables.
✔ Reliable global supply chain network
✔ Competitive export pricing for bulk buyers
✔ Strong focus on oncology & biologic medicines
✔ Compliance-oriented export documentation
✔ Support for hospitals, distributors & importers worldwide
✔ Expanding presence in regulated international markets
📦 Order & Global Enquiry
For hospital procurement, bulk export orders, pharmacy distribution, or personal import assistance:
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
⚠️ Disclaimer
Rituximab Biosimilar Injection is a prescription-only biologic medicine and should be used strictly under qualified medical supervision as per approved clinical guidelines in each country.